Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice.
Takeshi MorimotoKazutaka UchidaFumihiro SakakibaraNorito KinjoShinichiro UedaPublished in: Pharmacoepidemiology and drug safety (2021)
APT in patients taking OACs for NVAF did not prevent ischemic events but significantly increased major bleedings in the real-world setting.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- end stage renal disease
- antiplatelet therapy
- newly diagnosed
- ejection fraction
- clinical practice
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- physical activity
- patient reported outcomes
- brain injury
- direct oral anticoagulants
- oxidative stress
- catheter ablation
- mitral valve